Ischemia Modified Albumin: A Novel Biomarker for the Detection of Cardiac Ischemia
Drug Metabolism and Pharmacokinetics, 2009 The diagnosis of cardiac ischemia remains a challenge in contemporary emergency medicine. A blood-borne biomarker is an attractive alternative to cardiac imaging or stress testing as it would be cheaper and logistically faster to obtain. A number of candidate biomarkers have been proposed for the detection of cardiac ischemia; however, only Ischemia ...
David Gaze
exaly +3 more sources
The Role of ischemia modified albumin in acute pulmonary embolism
Heart Views, 2014 Background: Acute pulmonary embolism (PE) is a life-threatening and a relatively common cardiovascular pathology. Although the pathogenesis of PE is well defined, there is no ideal diagnostic biochemical marker.
Zeynettin Kaya +9 more
doaj +3 more sources
Ischemia modified albumin and thiol/disulfide balance in patients with Hashimoto’s thyroiditis [PDF]
The Ukrainian Biochemical Journal, 2022 Hashimoto thyroiditis is a common cause of goiter and acquired hypothyroidism in individuals residing in areas of no iodine deficiency. The fact that the structure of serum albumin exhibits changes in ischemic conditions has paved the way for the ...
E. Avci +3 more
doaj +1 more source
Value of thiol and ischemia modified albumin (IMA) in predicting mortality in serious COVID-19 pneumonia. [PDF]
Heliyon, 2022 Acar T, Ertekin B, Yortanli M.
europepmc +2 more sources
Clinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients. [PDF]
PLoS ONE, 2013 BACKGROUND: Ischemia-modified albumin is an altered serum albumin that forms under conditions of oxidative stress, a state also associated with doxorubicin-induced myocardial injury.
Yinghuan Ma +4 more
doaj +1 more source
Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium, [PDF]
Anais Brasileiros de Dermatologia, 2020 Background Telogen effluvium is the most common form of non-scarring alopecia characterized by diffuse hair loss. Ischemia-modified albumin is a marker of oxidative stress and inflammation.
Unsal Savci +5 more
doaj +1 more source
Taiwanese Journal of Obstetrics & Gynecology, 2023 Objective: This study investigates the relationship between Ischemia Modified Albumin and Total-Sulphydryl levels with some subclinical inflammatory markers in patients with hyperemesis gravidarum.
Kazım Uçkan, Halit Demir, Canan Demir
doaj +1 more source
Ischemia-Modified Albumin (IMA) for early detection of myocardial ischemia in acute coronary syndrome with type 2 diabetes mellitus: a case control study [PDF]
Perspectives In Medical Research, 2023 Introduction: Evaluation of the patients who present to the hospital with a complaint of chest pain or other signs suggestive of acute coronary syndrome (ACS) is time-consuming, expensive, and difficult.
Mehraj A Junedi, Abdulazim A Junaidi
doaj +1 more source
Ischemia-Modified Albumin during Skeletal Muscle Ischemia [PDF]
Clinical Chemistry, 2004 Ischemia-modified albumin (IMA) has been proposed as a biological marker of myocardial ischemia (1)(2). Exposure to ischemic myocardium modifies circulating albumin at its NH2 terminus by different mechanisms, and this modification is the basis of IMA measurement by the albumin cobalt binding (ACB) test (3).
Edgar, Zapico-Muñiz +5 more
openaire +2 more sources
The role of Ischemia modified albumin in detecting diabetic nephropathy
SVU - International Journal of Medical Sciences, 2023 Background: Ischemia-modified albumin (IMA) is considered a marker of oxidative stress and ischemia. Objectives: In this study, we aimed at establishing an association between IMA and diabetic nephropathy (DN) in type2 Diabetes mellitus (T2DM) patients.
Asmaa Ali Mahmoud Ahmed +3 more
doaj +1 more source